NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

LP likely knows NICE will never pay for L given the high cost and nebulous trial, and MHRA wants LP to work it out with NICE before they green light it or just stay with Specials.

The goal was already achieved when Advent leased Sawston and created a CDMO. LP was likely pressured into folding Advent into NWBO either by a group of shareholders or financiers / both, IMO.


>>Ex, can you guess whether the company actually knows why their approval is being delayed, or are they in the same position as us, clueless? In my opinion, if the goal was to create a CDMO, they should have done it before the Advent merger and kept Advent as a separate entity.